Carerx Corporation · TSX:CRRX
Carerx — Investor Presentation (November 2022)
18 slides from Carerx's investor presentation, November 2022
Slide 1: Canada's Largest Seniors Care Pharmacy Provider
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Investor Presentation November 2022
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: Canada's largest and fastest growing provider of pharmacy services to seniors
Canada’s largest and fastest growing provider of pharmacy services to seniors housing communities and other congregate care settings 3 3
Slide 4: Medication management is a critical component of seniors care
The typical senior Medication supply and in a long-term management is a critical care or retirement component of seniors home care home takes • Optimize medication regimen for optimal 4 to 12 resident outcomes • Ensure highest levels of safety • Minimize hospital visits medications daily 4 Never has
Slide 5: Comprehensive Institutional Pharmacy Services Offering
Comprehensive Institutional Pharmacy Services Offering Dispensing Clinical and Support Equipment and Services Services Technology • High-volume solutions for cost- • Pharmacist led medication • Medication and treatment carts with effective supply of all medications reconciliation for new admissions
Slide 6: Growing National Scale: >95,000 beds serviced
Strongest Network in the Sector Growing National Scale PacMed/PacVision equipment >95,000 beds serviced at all locations Geographies: Ontario, Western Canada seniors housing and expanding to Atlantic Provinces >1,600 communities Strong Bed Growth fulfillment >95,000 28 centres 1 100000 80000 60000 3
Slide 7: Seniors housing beds and congregate care settings in Canada
Seniors housing beds and Next ~15 years congregate care settings in Number of beds in Canada Canada ~500,0001 (and growing) forecast to grow >2x 1,025,000 19% >95,000 beds ~500,000 81% 1. Other bed opportunities available, including group homes, corrections facilities and other congregate care livin
Slide 8: Organic Growth: Well Positioned to Capitalize on a Transforming Market
Organic Growth: Well Multiple Opportunities for Organic Growth Positioned to Capitalize on a Transforming Market Grow with existing customers as they expand • Acquisitions Canadian LTC industry has • New home builds commenced a period of substantial expansion & consolidation • New bed license alloca
Slide 9: Announced Expansion to Atlantic Canada
Announced Expansion to Atlantic Canada Largest Network in the Sector October 3, 2022: Announced a multi-year contract to provide pharmacy services to residents in multiple seniors living facilities in Atlantic Canada • Establishing pharmacy services operations in Atlantic Canada • Initially serving
Slide 10: Successful Execution of Acquisition Strategy
Successful Execution of Acquisition Strategy Proven ability to acquire at accretive multiples, rapidly integrate and realize synergies May 2020 April 2021 June 2021 August 2021 March 2022 Remedy’sRx SmartMeds Rexall Medical Hogan Specialty Pharmacy Pharmacies Pharmacy Partners LTC Pharmacy +18,500 b
Slide 11: Successful Execution of Our Growth Strategy
Successful Execution of Our Growth Strategy Avg. Beds Serviced Revenue Adj. EBITDA Revenue Adj. EBITDA (000s) (from continuing ops) (from continuing ops) (from continuing ops) (from continuing ops) ($ millions) ($ millions) ($ millions) ($ millions) 7.7 384.4 32.7 96.5 97.4 6.9 81.8 71.3 262.6 22.9
Slide 12: Continued Long-Term Growth Trajectory
Continued Long-Term Growth Trajectory 19% >95,000 beds Continued confidence in organic growth 81% prospects • Robust business development pipeline • New bed license allocations to existing Market Opportunity via Organic Growth & customers Acquisitions • Beds in Canada expected to double in 15 years
Slide 13: 2022 ESG Report
2022 ESG Report Environmental, Social & Governance initiatives have long been an important part of CareRx’s identity and are reflected in our core values Our 2022 ESG Report outlines our commitment to health and safety, employee engagement, diversity, equity and inclusion, data privacy and security,
Slide 14: Investment highlights
1 2 3 Large, high-growth Canada’s largest Leading customer seniors living market seniors care value proposition and pharmacy provider national network 4 5 Compelling organic Significant operating and acquisition leverage growth opportunities 14 www.carerx.ca
Slide 15: Appendix
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Appendix
Slide 16: Balance Sheet
Balance Sheet At September 30/22 Total Debt1 at September 30/22 Cash $17.9 M $13.2 M Net Debt1 $75.3 M $20.0 M $60.0 M Net Debt to Adjusted EBITDA2 2.4x March 2019 Convertible Debentures Subordinated Debt Senior Debt 16 1. Debt = borrowings (principal) not including November 2019 Convertible Debentu
Slide 17: Capital Structure
Capital Structure Shares Outstanding (000’s) Ownership 2,140 56,137 60,000 6,250 Fully Diluted Ownership 47,747 Yorkville Asset Management 13,558,307 24.2% 40,000 Management & Insiders 12,424,373 22.1% Other 30,154,644 53.7% 20,000 Total 56,137,324 100% 0 Current I/O Convertible Other Outstanding To
Slide 18: Investor Presentation
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Investor Presentation November 2022